NSEInvestor Presentation4d ago · 5 Nov 2026, 10:05 pm
Investor Presentation
Godavari Biorefineries Limited · GODAVARIB
✦ AI Summary▲ PositiveResults
Godavari Biorefineries Limited has informed the Exchange about Investor Presentation for the quarter and half year ended September 30, 2026, with highlights of consolidated Q2 & H1 FY27 performance, revenue mix, and consolidated P&L statement.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Godavari Biorefineries Limited has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
GODAVARIBIO_05112026220534_Intimation_to_SE.pdf
View document text
Dated: November 5, 2026
The Manager The Manager
Listing Department Listing Department
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower,
Bandra Kurla Complex, Bandra (E), Dalal Street
Mumbai – 400 051 Mumbai-400001
Script Symbol: GODAVARIB Script Code:544279
Dear Sir / Madam,
Sub: INVESTOR PRESENTATION
Dear Sir / Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, please find enclosed herewith the Investor Presentation for the quarter and
half year ended September 30, 2026
This is for your information and records.
Thanking you,
Yours faithfully
For Godavari Biorefineries Limited
Manoj Jain
Company Secretary & Compliance O(cid:431)icer
Membership No. F-7998
Godavari Biorefineries Limited
Investor Presentation | Q2 & H1 FY27
CREATING
a Beautiful World
With Innovation at the Core,
Unified in Growth, Sustainability & Inclusivity.
Safe Harbor
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Godavari Biorefineries Limited (the “Company’), have been prepared
solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be
relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering
document containing detailed information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or
warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this
Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of,
or any omission from, this Presentation is expressly excluded.
Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and
collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks,
uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the
economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its
strategy, the Company's future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cashflows, the
Company's market preferences and its exposure to market risks, as well as other risks. The Company's actual results, levels of activity, performance or achievements could
differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information
contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the
Company is not responsible for such third-party statements and projections. All Maps used in the presentation are not to scale.
All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness.
Godavari Biorefineries Limited 2
Q2 & H1 FY27 Highlights
Consolidated Q2 & H1 FY27 Performance
Q2 FY27 | QUARTERLY PERFORMANCE H1 FY27 | HALF-YEAR PERFORMANCE
TOTAL REVENUE Q2 FY27 | QUEABRITTDERALY PERFORMANCE EBITDA MARGIN TOTAL REVENUEH1 FY27 | HALF-Y EEA BR IT P DE ARFORMANCE EBITDA MARGIN
549.8 10.9 2.0 % 1109.7 13.4 1.2%
968.2
434.4
2.1 0.2%
Q2 FY26 Q2 FY27 (4.4) (1.0)% H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27
Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27
+27% YoY Turned +ve Turned +ve +15% YoY +543% YoY +99 bps
Godavari Biorefineries Limited 4
Bio-based Chemicals Segment
Q2 FY27 | QUARTERLY PERFORMANCE H1 FY27 | HALF-YEAR PERFORMANCE
TOTAL REVENUE EBITDA EBITDA MARGIN TOTAL REVENUE EBITDA EBITDA MARGIN
204.2 22.1 10.8 % 372.9 41.2 11.1%
10.2 %
9.6%
288.3
147.1
15.0 27.6
Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27
+39% YoY +47% YoY +60 bps +29% YoY +50% YoY +150 bps
The segment’s performance was supported by ongoing debottlenecking initiatives and improved operational efficiencies, driving higher revenue and EBITDA growth alongside an
improvement in margins during the first half of FY27.
Godavari Biorefineries Limited 5
Integrated Sugar, Co-generation & Ethanol Segment
Q2 FY27 | QUARTERLY PERFORMANCE H1 FY27 | HALF-YEAR PERFORMANCE
TOTAL REVENUE EBITDA EBITDA MARGIN TOTAL REVENUE EBITDA EBITDA MARGIN
334.2 712.1
658.6
275.7
(2.6)%
(8.7)
(18.4) (6.7)% (22.7) (23.3) (3.4)% (3.3)%
Q2 FY26 Q2 FY27 H1 FY26 H1 FY27
Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27
The segment’s performance was impacted by challenging feedstock conditions, higher manufacturing costs and lower ethanol tender allotments resulting in shrinkage in the margins
for the first half of FY27.
Godavari Biorefineries Limited 6
Revenue Mix
QUARTERLY HALF YEARLY
2% 2% 2% 2%
34% 34%
Rs. 430.8 Cr
Rs. 549.2 Cr Rs. 964.0 Cr Rs. 1107.1 Cr
Q2 FY26
Q2 FY27 H1 FY26 H1 FY27
64% 64%
Integrated Sugar, Co-generation and Ethanol Bio-Based Chemicals Unallocated
Godavari Biorefineries Limited 7
Consolidated P&L Statement
Particulars (in INR Crs) Q2 FY27 Q2 FY26 Y-o-Y Q1 FY27 Q-o-Q H1 FY27 H1 FY26 Y-o-Y
Revenue from Operations 549.2 430.8 557.9 1107.1 964.0
Other Income 0.5 3.5 2.0 2.6 4.3
Total Income 549.8 434.3 26.6% 559.9 (1.8)% 1,109.7 968.2 14.6%
Cost of Materials Consumed 220.4 146.2 185.5 405.9 351.7
Purchase of Finished Goods 10.6 9.5 10.4 21.0 17.8
Changes in Inventories of Finished Goods and WIP 198.7 187.2 263.2 462.0 404.9
Gross Profit 120.0 91.4 31.3% 100.9 19.0% 220.8 193.8 14.0%
GP % 21.8% 21.0% 18.0% 19.9% 20.0%
Employee Benefits Expense 36.6 31.5 33.0 69.6 63.7
Other Expenses 72.5 64.2 65.3 137.8 128.0
EBITDA* 10.9 (4.4) 2.6 322.3% 13.4 2.1 542.6%
EBITDA % 2.0% (1.0)% 0.5% 1.2% 0.2%
Depreciation and Amortisation Expense 15.2 13.5 14.5 29.7 27.0
EBIT (4.4) (17.9) (75.7)% (11.9) (63.5)% (16.3) (24.9) (34.7)%
Finance Costs 15.4 12.3 13.9 29.3 27.6
Profit before exceptional expense (19.7) (30.2) (34.7)% (25.8) (23.6)% (45.6) (52.5) (13.2)%
Exceptional Expenses 0.0 26.7 0.0 0.0 26.7
Profit/(Loss) before tax for the period (19.7) (56.9) (65.3)% (25.8) (23.6)% (45.6) (79.2) (42.4)%
Tax Expense (4.5) (15.3) (6.5) (11.0) (21.6)
Profit/(Loss) after Tax (15.2) (41.6) (63.4)% (19.3) (21.1)% (34.6) (57.6) (40.0)%
Godavari Biorefineries Limited 8
Consolidated Balance Sheet
Particulars (in INR Cr) Sep 26 Mar 26 Particulars (in INR Cr) Sep 26 Mar 26
ASSETS EQUITY AND LIABILITIES
Non-current assets EQUITY
(i) Equity share capital 51.2 51.2
(a) Property, plant and equipment 959.7 864.1
(ii) Other equity 701.9 737.1
(b) Capital Work-in-Progress 0.5 0.7
Total Equity 753.1 788.3
(c) Right to use Asset 55.4 129.3
LIABILITIES
(d) Intangible Asset 1.3 1.2
Non-current liabilities
(e) Intangible Assets Under Development 21.1 18.6
(i) Financial Liabilities
(f) Investment accounted for equity method 0.0 0.0
-Borrowings 324.4 333.3
(g) Financial Assets
-Lease Liabilities 0.4 0.5
(i) Investments 0.1 0.1 -Other financial liabilities 9.8 9.5
(ii) Trade Receivables 0.4 0.5 (ii) Provisions 3.3 3.0
(iii) Other financial assets 17.2 19.0 (iii) Deferred tax Liabilities 31.1 42.9
(h) Other Non-current assets 27.6 27.3 (iv) Other Non-Current Liabilities 0.4 0.4
Total non-current assets 1083.4 1060.7 Total Non-Current Liabilit
[Showing first 8,000 characters — download PDF for full document]